Company profile: Nutriband
1.1 - Company Overview
Company description
- Provider of abuse-deterrent transdermal technologies and drug delivery systems, including the AVERSA platform integrating abuse-deterrent features into patches for fentanyl, buprenorphine, and methylphenidate, and 4P transdermal systems delivering Exenatide for Type 2 Diabetes and FSH for infertility.
Products and services
- AVERSA Transdermal Technology: Platform-level technology applied across various patches to incorporate abuse-deterrent features for drug-specific deterrence
- AVERSA Fentanyl Abuse Deterrent: Transdermal technology engineered to prevent fentanyl abuse by incorporating abuse-deterrent properties directly into fentanyl patches
- AVERSA Buprenorphine Abuse Deterrent: Transdermal system applied to buprenorphine patches to reduce potential misuse by embedding abuse-deterrent features within the patch
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nutriband
Xanadu Bio
HQ: United States
Website
- Description: Provider of nanoparticle delivery technology for mRNA and other nucleic acids, using PACE platform technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xanadu Bio company profile →
Vivani Medical
HQ: United States
Website
- Description: Provider of implantable visual prosthetics for blind individuals and developer of NanoPortal technology for miniature, subdermal drug implants delivering steady medication, including NPM-115 for chronic weight management and NPM-119 (under development) for type 2 diabetes; via subsidiary Cortigent, develops targeted neurostimulation for artificial vision and muscle movement restoration in stroke rehabilitation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vivani Medical company profile →
TriSalus
HQ: United States
Website
- Description: Provider of novel infusion systems for the interventional radiology market, including Pressure-Enabled Drug Delivery to overcome intratumoral pressure and enhance local drug concentrations; an integrated platform combining immunomodulation therapy with proprietary intravascular regional delivery for liver and pancreatic tumors; and investigational TLR9 agonist nelitolimod (SD-101), evaluated in ongoing PERIO-01 and PERIO-02 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriSalus company profile →
NuGen Medical Devices
HQ: Canada
Website
- Description: Provider of needle-free medical delivery technologies, including InsuJet, a spring-loaded injection system for self-administration by patients and healthcare practitioners that delivers drugs through the skin, and PetJet, a device for veterinary use facilitating painless, quick treatment for pets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuGen Medical Devices company profile →
Nano Precision Medical
HQ: United States
Website
- Description: Provider of miniaturized subdermal implants using the NanoPortal membrane to deliver steady, long-term therapeutics for chronic diseases. Offerings include the NanoPortal Platform Technology; NPM-115 for chronic weight management and NPM-119 for type 2 diabetes, each designed to provide steady medication for up to six months; and Cortigent neurostimulation systems for artificial vision and muscle movement restoration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nano Precision Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nutriband
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nutriband
2.2 - Growth funds investing in similar companies to Nutriband
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nutriband
4.2 - Public trading comparable groups for Nutriband
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →